Kevin Lee

Title: Kevin Lee - Innovator in Pharmaceutical Formulations

Introduction

Kevin Lee is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceutical formulations, particularly with his innovative approach to controlled release systems. His work focuses on enhancing the effectiveness of medications through advanced formulation techniques.

Latest Patents

Kevin Lee holds a patent for a buoyant controlled release powder formulation. This formulation is designed to be filled into capsules and releases a pharmaceutical of a basic character at a controlled rate, regardless of the pH of the environment. The formulation includes a basic pharmaceutical, up to about 45% by weight of a pH-dependent polymer, which is a salt of alginic acid, such as sodium alginate. Additionally, it contains up to about 35% by weight of a pH-independent hydrocarbon gelling agent, having a viscosity of up to about 100,000 centipoises in a 2% solution at 20°C, along with various excipients.

Career Highlights

Kevin Lee is associated with E. R. Squibb Sons, Inc., where he has been instrumental in developing innovative pharmaceutical products. His expertise in formulation science has contributed to advancements in drug delivery systems, making medications more effective and patient-friendly.

Collaborations

Throughout his career, Kevin has collaborated with several professionals in the field, including Andrew B. Dennis and Peter Timmins. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Kevin Lee's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in the medical field. His patent for a buoyant controlled release powder formulation showcases his commitment to improving drug delivery systems.